Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

8.7K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
8.7K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.4K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.4K
Design Example01:23

Design Example

446
The innovation of touch-tone telephony revolutionized the telecommunications industry by replacing the traditional rotary dial with a dual-tone multi-frequency (DTMF) signaling system. This system uses a matrix-style keypad with buttons arranged in four rows and three columns, creating 12 distinct signals each assigned to a pair of frequencies. Each button press results in a simultaneous generation of two sinusoidal tones – one from a low-frequency group (697 to 941 Hz) and one from a...
446

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Anthropometric Indices and Presence of Type 2 Diabetes Mellitus in Obesity.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026
Same author

Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study).

Cardiovascular diabetology. Endocrinology reports·2026
Same author

Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study).

Cureus·2026
Same author

Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes: Findings from PIONEER REAL India.

Indian journal of endocrinology and metabolism·2025
Same author

Risk Factor Analysis of Gestational Diabetes Mellitus Across Urban India: Findings from the Pregnancy Study Group.

Journal of obstetrics and gynaecology of India·2025
Same author

Colours of India: Uniting Endocrinologists in Fitness and Friendship.

Indian journal of endocrinology and metabolism·2024

Related Experiment Video

Updated: Nov 28, 2025

Glass-Based Devices to Generate Drops and Emulsions
08:45

Glass-Based Devices to Generate Drops and Emulsions

Published on: April 5, 2022

3.0K

Gla-100 Development: a Story of 'Serendipitous' Disruptive Innovation.

Mohan Badgandi1, Vijay Negalur2, P Sudhakar Reddy3

  • 1Senior Consultant, Manipal Hospital, Bengaluru, Karnataka.

The Journal of the Association of Physicians of India
|November 28, 2020
PubMed
Summary

The development of basal insulins, like insulin glargine (Gla-100), aimed to improve glycemic control and reduce hypoglycemia risk compared to older options like neutral protamine Hagedorn (NPH) insulin.

More Related Videos

Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER
07:26

Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER

Published on: May 19, 2019

12.4K
Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
06:19

Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections

Published on: October 11, 2024

3.0K

Related Experiment Videos

Last Updated: Nov 28, 2025

Glass-Based Devices to Generate Drops and Emulsions
08:45

Glass-Based Devices to Generate Drops and Emulsions

Published on: April 5, 2022

3.0K
Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER
07:26

Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER

Published on: May 19, 2019

12.4K
Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
06:19

Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections

Published on: October 11, 2024

3.0K

Area of Science:

  • Endocrinology
  • Pharmacology
  • Diabetology

Background:

  • Insulin therapy is crucial for managing diabetes, but early basal insulins posed risks.
  • Neutral protamine Hagedorn (NPH) insulin, an intermediate-acting option, was associated with a high risk of hypoglycemia.
  • The need for improved basal insulins with longer action profiles and reduced hypoglycemia risk became evident.

Purpose of the Study:

  • To review the historical context and scientific journey leading to the development of truly basal insulins.
  • To highlight the evolution of basal insulin therapy, focusing on insulin glargine 100 U/mL (Gla-100).

Main Methods:

  • Literature review of historical developments in insulin therapy.
  • Analysis of pharmacological properties and clinical outcomes of early and modern basal insulins.

Main Results:

  • Insulin glargine (Gla-100) emerged as a superior basal insulin due to its prolonged duration of action and significantly lower risk of hypoglycemia compared to NPH.
  • Insulin glargine offers enhanced glycemic control, addressing limitations of earlier insulin formulations.

Conclusions:

  • The development of insulin glargine (Gla-100) represents a significant advancement in basal insulin therapy.
  • Insulin glargine provides a more effective and safer option for achieving holistic glycemic control in diabetes management.